Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Fang Liu , Centre for Addiction and Mental Health × Clear Filters

1 results found

Late stage pre‐clinical development of a small molecule compound for re‐myelination and functional recovery in multiple sclerosis through disruption of the AMPA‐GAPDH complex

While it is the immune system that damages the brain in MS, the way this damage is caused involves many processes.

Project ongoing See Project & Researchers
Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Therapeutic Development Opportunities Addressing MS
Province
Ontario
Start Date
2025